West Michigan Advisors LLC bought a new position in shares of Zomedica Corp. (NYSEAMERICAN:ZOM – Free Report) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund bought 389,710 shares of the company’s stock, valued at approximately $47,000.
Separately, Geode Capital Management LLC grew its stake in Zomedica by 3.3% in the 3rd quarter. Geode Capital Management LLC now owns 9,929,716 shares of the company’s stock valued at $1,363,000 after buying an additional 321,395 shares during the last quarter. Institutional investors own 8.95% of the company’s stock.
Zomedica Trading Up 3.6 %
ZOM opened at $0.11 on Friday. Zomedica Corp. has a 52-week low of $0.09 and a 52-week high of $0.20. The firm has a market cap of $106.23 million, a PE ratio of -1.81 and a beta of 1.03.
Analyst Upgrades and Downgrades
Read Our Latest Analysis on ZOM
Zomedica Profile
Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company offers diagnostic products comprising TRUFORMA Bulk Acoustic Wave point of care diagnostic platform; TRUVIEW, a digital cystoscopy platform that offers automated slide preparation within the instrument; and VetGuardian, a zero-touch vital signs remote monitoring system.
Read More
- Five stocks we like better than Zomedica
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- Autodesk Designs Value for Investors: Uptrend Set to Continue
- How is Compound Interest Calculated?
- Anheuser-Busch Stock Rallies—Is the King of Beers Back?
- What is a Death Cross in Stocks?
- MarketBeat Week in Review – 02/24 – 02/28
Receive News & Ratings for Zomedica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zomedica and related companies with MarketBeat.com's FREE daily email newsletter.